Novel findings shed light on the mechanisms whereby PPARγ agonists, such as rosiglitazone, induce browning of white adipocytes. In human adipocytes, rosiglitazone triggered a specific 'brown-in-white' (brite) adipocyte gene programme that increased mitochondrial oxidative capacity. Browning induced reprogramming of PPARγ binding, with PPARγ 'superenhancers' being associated with the brite-selective programme. KLF11 was identified as a novel transcription factor that is activated by PPARγ and cooperates with it to induce and maintain the brite-selective programme.